Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare disease.
Martin-Geary AC. et al, (2025), Genome Med, 17
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.
Cheerie D. et al, (2025), Am J Hum Genet
Contribution of autosomal rare and de novo variants to sex differences in autism
Koko M. et al, (2025), American Journal of Human Genetics, 112, 599 - 614
LARP1 haploinsufficiency is associated with an autosomal dominant neurodevelopmental disorder.
Chettle J. et al, (2024), HGG Adv, 5
Nr2f1 enhancers have distinct functions in controlling Nr2f1 expression during cortical development.
Liu Z. et al, (2024), Proc Natl Acad Sci U S A, 121
Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements.
Chardon FM. et al, (2024), Nat Commun, 15
The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review.
Herzeg A. et al, (2024), Prenat Diagn
De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome.
Chen Y. et al, (2024), Nature
Sex-Differential Gene Expression in Developing Human Cortex and Its Intersection With Autism Risk Pathways
Kissel LT. et al, (2024), Biological Psychiatry Global Open Science, 4
Five autism-associated transcriptional regulators target shared loci proximal to brain-expressed genes.
Fazel Darbandi S. et al, (2024), Cell Rep, 43
CWAS-Plus: estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data.
Kim Y. et al, (2024), Brief Bioinform, 25
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants.
Silva DB. et al, (2024), Am J Hum Genet
A comprehensive AI model development framework for consistent Gleason grading.
Huo X. et al, (2024), Commun Med (Lond), 4